2.4. Analysis.
Comparison 2 Oxytocin versus no uterotonics or placebo‐subgroup analyses, Outcome 4 Need for additional uterotonics; active v. expectant management.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.